| Literature DB >> 35733895 |
Claudio Monasterolo1, Ryan O'Gara1, Saranna E Kavanagh1, Sadbh E Byrne1, Bartosz Bieszczad1, Orla Murray1, Michael Wiesinger1, Rebecca A Lynch1, Kirill Nikitin1, Declan G Gilheany1.
Abstract
A new class of biaryl chiral ligands derived from 1,2-diaminocyclohexane (1,2-DACH) has been designed to enable the asymmetric addition of aliphatic and, for the first time, aromatic Grignard reagents to ketones for the preparation of highly enantioenriched tertiary alcohols (up to 95% ee). The newly developed ligands L12 and L12' together with the previously reported L0 and L0' define a set of complementary chiral promoters, which provides access to the modular construction of a broad range of structurally diverse non-racemic tertiary alcohols, bearing challenging quaternary stereocenters. The present advancements bring to completion our asymmetric Grignard methodology by expanding the scope to aromatic organomagnesium reagents, while facilitating its implementation in organic synthesis thanks to improved synthetic routes for the straightforward access to the chiral ligands. The synthetic utility of the method has been demonstrated by the development of a novel and highly enantioselective formal synthesis of the antihistamine API clemastine via intermediate (R)-3a. Exploiting the power of the 3-disconnection approach offered by the Grignard synthesis, (R)-3a is obtained in 94% ee with ligand (R,R)-L12. The work described herein marks the finalization of our ongoing effort towards the establishment of an effective and broadly applicable methodology for the asymmetric Grignard synthesis of chiral tertiary alcohols. This journal is © The Royal Society of Chemistry.Entities:
Year: 2022 PMID: 35733895 PMCID: PMC9159101 DOI: 10.1039/d1sc06350b
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.969
Scheme 1Modular construction of chiral tertiary alcohols via ligand-mediated, single metal based asymmetric Grignard synthesis.
Scheme 2(a) Our asymmetric Grignard synthesis of chiral tertiary alcohols mediated by DACH-derived ligands L0 and L0′ and application to the preparation of valuable natural products and APIs. (b) Newly designed biaryl ligands L12 and L12′ for the enantioselective addition of both alkyl and aryl Grignard reagents to ketones.
Scheme 3Synthetic routes for the preparation of DACH-derived chiral ligands. Route (a) new two-step, one-pot synthesis of alkyl-substituted ligands L0–L3. Route (b) preparation of halogenated ligands L4–L6 (X = F, Cl, Br) and divergent synthesis of novel biaryl ligands L7–L14via late-stage diversification of the common intermediate L6via cross-coupling arylation with aryl boronic acids.
Screening of new biaryl ligands L1–L14 in the addition of EtMgBr to acetophenonea
|
| |||
|---|---|---|---|
| Entry | ( | ( | ( |
| 1 | L0 | 55 | 78 |
| 2 | L0′ | 80 | 93 |
| 3 | L1 | 77 | 23 |
| 4 | L2 | 47 | 67 |
| 5 | L3 | 43 | 67 |
| 6 | L4 | 40 | 51 |
| 7 | L5 | 53 | 63 |
| 8 | L6 | 50 | 65 |
| 9 | L7 | 50 | 81 |
| 10 | L8 | 70 | 79 |
| 11 | L9 | 50 | 85 |
| 12 | L10 | 63 | 82 |
| 13 | L11 | 40 | 78 |
| 14 | L12 | 63 | 87 |
| 15 | L13 | 70 | 81 |
| 16 | L14 | 20 | 50 |
Acetophenone 1a 0.5 M in dry toluene (0.1 mmol), ligand (R,R)-L0–L14 (0.11 mmol), EtMgBr 3.0 M in Et2O (0.22 mmol), in dry toluene (1.2 mL). The Grignard reagent in Et2O was diluted with dry toluene (0.4 mL, ca. 1 : 6), see ESI for detailed procedures.
Conversion and ee determined by HPLC analysis on chiral stationary phase of the crude reaction mixture after work-up. The crude mixture contained only product and starting material.
Asymmetric Grignard synthesis of chiral dialkyl-aryl tertiary alcohols 2a–h mediated by (R,R)-L12a,b,c
|
|
|---|
|
|
Procedure as for Table 1, EtMgBr 3.0 M in Et2O, MeMgBr 3.0 M in Et2O.
Isolated yields, unless otherwise stated.
Enantiomeric excess determined by HPLC analysis on chiral stationary phase of the crude reaction mixture after work-up.
Absolute configuration determined by comparison with literature.
Conversion determined by 1H-NMR analysis of the crude reaction mixture.
Absolute configuration determined by X-ray crystallographic analysis of the carbamate derivative, see ESI for details.
Screening of biaryl ligands L7–L14 in the asymmetric 1,2-addition of para-chlorophenylmagnesium bromide to acetophenonea
|
| |||
|---|---|---|---|
| Entry | ( | ( | ( |
| 1 | L0 | 51 | 21 |
| 2 | L7 | 46 | 39 |
| 3 | L8 | 38 | 43 |
| 4 | L9 | n.d. | 31 |
| 5 | L11 | n.d. | 36 |
| 6 | L12 | 78 | 89 |
| 7 | L12′ | 44 | 82 |
| 8 | L14 | n.d. | 14 |
Procedure as for Table 1, using para-chlorophenylmagnesium bromide 1.0 M in Et2O.
Conversion and ee determined by HPLC analysis on chiral stationary phase of the crude reaction mixture after work-up. The crude mixture contained only product and returned starting material.
Isolated yield. n.d. = not determined.
Asymmetric Grignard synthesis of chiral diaryl-alkyl tertiary alcohols 3a–m mediated by biaryl ligands (R,R)-L12 and (R,R)-L12′a,b,c
|
|
|---|
|
|
Procedure as for Table 1.
Isolated yields, unless otherwise stated.
Enantiomeric excess determined by HPLC analysis on chiral stationary phase of the crude reaction mixture after work-up.
Absolute configuration determined by comparison with previously reported results.
Using alternative order of addition optimized for the synthesis of clemastine, see ESI.
Conversion determined by 1H-NMR analysis of the crude reaction mixture after work-up.
Scheme 4Modular access to highly enantioenriched (R)-3a, key intermediate in the synthesis of the antihistamine API clemastine.
Scheme 5Proposed mononuclear ligand–Mg complex generated via deprotonation of (R,R)-L0 with EtMgBr.
Fig. 1Molecular structure of the ligand–Mg complex C1, precipitated from toluene following deprotonation of (S,S)-L0 with EtMgBr in Et2O.
Scheme 6Proposed equilibrium involving diastereomeric mononuclear ligand–Mg complexes C2, resulting from deprotonation of (R,R)-L0 with EtMgBr in Et2O.
Fig. 2DFT calculated molecular structures of R(N1)-C2 (a) and S(N1)-C2 (b).